144 related articles for article (PubMed ID: 29193344)
41. Enzyme-responsive cell-penetrating peptide conjugated mesoporous silica quantum dot nanocarriers for controlled release of nucleus-targeted drug molecules and real-time intracellular fluorescence imaging of tumor cells.
Li J; Liu F; Shao Q; Min Y; Costa M; Yeow EK; Xing B
Adv Healthc Mater; 2014 Aug; 3(8):1230-9. PubMed ID: 24550203
[TBL] [Abstract][Full Text] [Related]
42. Cancer-cell-specific induction of apoptosis using mesoporous silica nanoparticles as drug-delivery vectors.
Rosenholm JM; Peuhu E; Bate-Eya LT; Eriksson JE; Sahlgren C; Lindén M
Small; 2010 Jun; 6(11):1234-41. PubMed ID: 20486218
[TBL] [Abstract][Full Text] [Related]
43. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
[TBL] [Abstract][Full Text] [Related]
44. DNA-Hybrid-Gated Photothermal Mesoporous Silica Nanoparticles for NIR-Responsive and Aptamer-Targeted Drug Delivery.
Zhang Y; Hou Z; Ge Y; Deng K; Liu B; Li X; Li Q; Cheng Z; Ma P; Li C; Lin J
ACS Appl Mater Interfaces; 2015 Sep; 7(37):20696-706. PubMed ID: 26325285
[TBL] [Abstract][Full Text] [Related]
45. Design of enzyme-mediated controlled release systems based on silica mesoporous supports capped with ester-glycol groups.
Agostini A; Mondragón L; Pascual L; Aznar E; Coll C; Martínez-Máñez R; Sancenón F; Soto J; Marcos MD; Amorós P; Costero AM; Parra M; Gil S
Langmuir; 2012 Oct; 28(41):14766-76. PubMed ID: 22998170
[TBL] [Abstract][Full Text] [Related]
46. Ordered mesoporous polymer-silica hybrid nanoparticles as vehicles for the intracellular controlled release of macromolecules.
Kim TW; Slowing II; Chung PW; Lin VS
ACS Nano; 2011 Jan; 5(1):360-6. PubMed ID: 21162552
[TBL] [Abstract][Full Text] [Related]
47. Poly(propylene imine) dendrimer caps on mesoporous silica nanoparticles for redox-responsive release: smaller is better.
Nadrah P; Porta F; Planinšek O; Kros A; Gaberšček M
Phys Chem Chem Phys; 2013 Jul; 15(26):10740-8. PubMed ID: 23689395
[TBL] [Abstract][Full Text] [Related]
48. Phospholipid-functionalized mesoporous silica nanocarriers for selective photodynamic therapy of cancer.
Teng IT; Chang YJ; Wang LS; Lu HY; Wu LC; Yang CM; Chiu CC; Yang CH; Hsu SL; Ho JA
Biomaterials; 2013 Oct; 34(30):7462-70. PubMed ID: 23810081
[TBL] [Abstract][Full Text] [Related]
49. Intracellular delivery of antisense peptide nucleic acid by fluorescent mesoporous silica nanoparticles.
Ma X; Devi G; Qu Q; Toh DF; Chen G; Zhao Y
Bioconjug Chem; 2014 Aug; 25(8):1412-20. PubMed ID: 25055196
[TBL] [Abstract][Full Text] [Related]
50. Intracellular pH-Triggered, Targeted Drug Delivery to Cancer Cells by Multifunctional Envelope-Type Mesoporous Silica Nanocontainers.
Yang K; Luo H; Zeng M; Jiang Y; Li J; Fu X
ACS Appl Mater Interfaces; 2015 Aug; 7(31):17399-407. PubMed ID: 26196506
[TBL] [Abstract][Full Text] [Related]
51. Influence of protein corona on the transport of molecules into cells by mesoporous silica nanoparticles.
Paula AJ; Araujo Júnior RT; Martinez DS; Paredes-Gamero EJ; Nader HB; Durán N; Justo GZ; Alves OL
ACS Appl Mater Interfaces; 2013 Sep; 5(17):8387-93. PubMed ID: 23841723
[TBL] [Abstract][Full Text] [Related]
52. Esterase- and pH-responsive poly(β-amino ester)-capped mesoporous silica nanoparticles for drug delivery.
Fernando IR; Ferris DP; Frasconi M; Malin D; Strekalova E; Yilmaz MD; Ambrogio MW; Algaradah MM; Hong MP; Chen X; Nassar MS; Botros YY; Cryns VL; Stoddart JF
Nanoscale; 2015 Apr; 7(16):7178-83. PubMed ID: 25820516
[TBL] [Abstract][Full Text] [Related]
53. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
Hu X; Wang Y; Peng B
Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
[TBL] [Abstract][Full Text] [Related]
54. pH-Triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids.
Muhammad F; Guo M; Qi W; Sun F; Wang A; Guo Y; Zhu G
J Am Chem Soc; 2011 Jun; 133(23):8778-81. PubMed ID: 21574653
[TBL] [Abstract][Full Text] [Related]
55. Binding and Kinetic Analysis of Human Protein Phosphatase PP2A Interactions with Caspase 9 Protein and the Interfering Peptide C9h.
Dorgham K; Murail S; Tuffery P; Savier E; Bravo J; Rebollo A
Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297489
[TBL] [Abstract][Full Text] [Related]
56. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
Xie Z; Gong H; Liu M; Zhu H; Sun H
J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
[TBL] [Abstract][Full Text] [Related]
57. Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells.
Sarkar A; Ghosh S; Chowdhury S; Pandey B; Sil PC
Biochim Biophys Acta; 2016 Oct; 1860(10):2065-75. PubMed ID: 27392941
[TBL] [Abstract][Full Text] [Related]
58. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.
Morelli C; Maris P; Sisci D; Perrotta E; Brunelli E; Perrotta I; Panno ML; Tagarelli A; Versace C; Casula MF; Testa F; Andò S; Nagy JB; Pasqua L
Nanoscale; 2011 Aug; 3(8):3198-207. PubMed ID: 21725561
[TBL] [Abstract][Full Text] [Related]
59. A controlled-release nanocarrier with extracellular pH value driven tumor targeting and translocation for drug delivery.
Zhao Z; Meng H; Wang N; Donovan MJ; Fu T; You M; Chen Z; Zhang X; Tan W
Angew Chem Int Ed Engl; 2013 Jul; 52(29):7487-91. PubMed ID: 23757374
[TBL] [Abstract][Full Text] [Related]
60. Hierarchically mesoporous silica nanoparticles: extraction, amino-functionalization, and their multipurpose potentials.
Du X; He J
Langmuir; 2011 Mar; 27(6):2972-9. PubMed ID: 21332153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
